SCHEMBL5288480

SCHEMBL5288480

CC(C)=NN=c1scc(-c2ccc3ccccc3c2)n1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 9/20 0.41
MAOB P27338 8/20 0.41
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AR P10275 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
NFKB1 P19838 1/20 0.35
GFER P55789 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
ATP1A3 P13637 1/20 0.34
ATP1B2 P14415 1/20 0.34
ATP1A2 P50993 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5288475 1.00 MAOA (0.41) MAOAMAOBNPC1RAB9AMEN1
SCHEMBL5278228 0.83 SMN1; SMN2 (0.41) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL5283771 0.83 SMN1; SMN2 (0.43) NPC1RAB9AALDH1A1MAPTGFER
SCHEMBL5283764 0.83 SMN1; SMN2 (0.43) NPC1RAB9AALDH1A1MAPTGFER
SCHEMBL4616109 0.81 MAPT (0.42) MAOAMAOBNPC1RAB9AMEN1
SCHEMBL4616110 0.81 MAPT (0.42) MAOAMAOBNPC1RAB9AMEN1
SCHEMBL5282035 0.80 RXFP1 (0.45) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL5282033 0.80 RXFP1 (0.45) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL5284067 0.79 MAPT (0.42) KDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL5280844 0.79 IDO1 (0.40) NPC1RAB9AKMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAOA 1614/4885MAOB 1402/4885NPC1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.